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Introduction Norepinephrine (NE) is a first-line vasopressor used
in patients with septic shock. Because of its predominant α-
agonist effect, it is assumed to increase vasomotor tone and hence
the mean arterial pressure (MAP) without significant effect on the
cardiac index (CI). However, a potential beneficial effect on CI can
be expected from its venoconstrictor α-agonist-mediated effect
combined with an inotropic β1 agonist effect, provided that the
increase in left ventricular afterload is not excessive (high levels of
MAP). The aim of our study was to examine the cardiovascular
effect of NE when it induces marked changes in MAP.
Methods In an observational study of patients (n = 37) resuscitated
for septic shock, we analysed hemodynamic PiCCO data at two
consecutive time points where the MAP changed by more than
15% in response to either initiation or to change of doses of NE.
Two subgroups of patients were identified. The first subgroup
(MAPincr) consisted of 21 patients in whom the MAP increased by
more than 15% in response to either initiation of NE infusion
(n = 8) or increase in NE dose (from 1.7 ± 1.7 to 2.2 ± 1.4 mg/hour;
n = 13). The second subgroup (MAPdecr) consisted of 16 patients
in whom the MAP decreased by more than 15% in response to the
decrease in NE doses. For both subgroups, the time between the
two consecutive sets of measurements did not exceed 2 hours and
no other treatments that may alter hemodynamics were adminis-
tered within this period (fluids, hemofiltration, diuretics or other
catecholamines).
Results In the MAPincr subgroup, MAP increased from 56 ± 17 to
84 ± 12 mmHg (P < 0.05) while significant increases in CI (from
3.4 ± 1.0 to 3.7 ± 0.9 l/min/m2), stroke volume index (SVi) (from
37 ± 12 to 41 ± 11 ml/m2) and global end diastolic volume index
(GEDVi) (from 706 ± 203 to 767 ± 225 ml/m2) were observed.
Neither the heart rate nor the global ejection fraction (GEF) signifi-
cantly changed. In seven patients, the GEF markedly increased by
>15% in parallel to the increase in SVi. In the MAPdecr subgroup,
MAP decreased from 95 ± 12 to 70 ± 9 mmHg (P < 0.05). The CI
(from 3.5 ± 1.4 to 3.0 ± 0.9 l/min/m2) and GEDVi (from 815 ± 319
to 721 ± 253 ml/m2) decreased significantly, while the heart rate,
SVi (P = 0.07) and GEF did not change.
Conclusion In our septic shock patients, changes in MAP resulting
from increases or decreases in the doses of NE, were associated
with changes in CI related to changes in GEDVi (cardiac preload)
and in some patients to changes in systolic left ventricular function
evaluated by GEF. These findings suggest that administration of
NE in septic shock is associated not only with an increase in MAP
but also with an increase in systemic blood flow.
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Introduction Tissue Doppler imaging (TDI) is a novel technique
that measures myocardial velocity. The peak early diastolic mitral
annulus velocity (E′) offers a relatively preload-insensitive measure
of LV relaxation. There are scant data regarding its use in sepsis or
endotoxemia. This study sought to determine the effect of
endotoxemia upon TDI variables.
Methods With ethics committee approval, 10 male Sprague–
Dawley rats were studied. Anesthesia was induced with alfaxalone
and maintained with isofluorane. Mechanical ventilation was
performed via tracheostomy. All rats received 0.9% NaCl 3 ml/hour
via a carotid line. Immediately after baseline assessment (T = 0),
rats received 1 ml/kg i.v. infusion over 30 minutes (study group
(n = 5), endotoxin 10 mg/ml (Escherichia coli O55:B5; Sigma,
MO, USA); control group, 0.9% NaCl). Echocardiography was
performed (15 MHz transducer, Vivid5; GE Healthcare) at T = 0,
60 minutes (T = 60) and 2.5 hours (T = 150). Measurements
included the heart rate, mean arterial pressure (MAP), femoral
venous pressure, LV outflow tract diameter and flow (peak velocity
(Vpeak), cardiac output (CO)), peak early diastolic mitral inflow (E),
peak systolic mitral annulus velocity (S′) and E′.
Results There was no significant difference in mean ± SD weight
(study 539 ± 88 g, control 504 ± 108 g, P = 0.6) or hemodynamic
variables at T = 0. At T = 60, only Vpeak was higher in the study
group compared with controls (1.29 ± 0.24 vs 0.86 ± 0.21 m/s,
P = 0.03). The study group demonstrated lower MAP, E and E′ at
T = 150 (Table 1).
Table 1 (abstract P38)
Control Study P
MAP (mmHg) 118 ± 21 75 ± 35 0.05
CO (l/min) 0.156 ± 0.02 0.181 ± 0.07 0.5
E (m/s) 1.02 ± 0.2 0.76 ± 0.11 0.04
E′ (m/s) 0.095 ± 0.02 0.061 ± 0.02 0.03
Conclusion In this model, endotoxemia was associated with a
decrease in E and E′. This decrease in E′ suggests a decreased
rate of myocardial relaxation. This has not previously been reported.
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Introduction The aim of this retrospective study is to evaluate
hemodynamic and neurohormonal effects of levosimendan in
cardiac patients with sepsis-induced cardiac dysfunction. Septic
shock is characterized by profound cardiovascular alterations
including myocardial depression. Levosimendan has recently been
shown to improve cardiac function in septic shock.
Methods Fifteen patients with myocardial depression related to
septic shock were enrolled. All patients had SIRS criteria, culture
isolation of one or more pathogens, positive procalcitonin, SBP
< 90 mmHg unresponsive to load challenge. We defined myo-
cardial depression as a reduced SvO2 in the presence of increased
brain natriuretic peptide secretion and Troponin I release, and
systolic and/or diastolic dysfunction by transoesophageal echo
evaluation of ejection fraction and mitral annulus tissue Doppler
imaging velocities. All patients received levosimendan infusion for
24 hours at 0.1 µg/kg/min combined with norepinephrine.
Results Data were obtained by evaluating the average of the
percentage variation between T0 (starting infusion) and T1
(24 hours after infusion), T2 (48 hours), T3 (72 hours), T4
(96 hours), T5 (120 hours) and T6 (144 hours). Levosimendan
significantly increased SvO2 and ejection fraction, and decreased
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